Detil Data Apalutamide

     
NAME : Apalutamide
BOBOT : 477.44
RUMUS : C21H15F4N5O2S
THERAPEUTIC INDC : Indicated for the treatment of patients with non-metastatic, castration-resistant prostate cancer (NM-CRPC) [FDA Label].
CATEGORIES : Androgen Antagonists / Antiandrogens / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strong) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (weak) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inducers (strong) / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 Enzyme Inducers / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3 Inhibitors / OATP1B1/SLCO1B1 Inducers / OCT2 Inhibitors / P-glycoprotein/ABCB1 Inducers
STRUCTURE :